CT矢状位重建在膈顶部肝肿瘤微波消融治疗中的应用

doi:10.6040/j.issn.1671-7554.0.2016.1195

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (8): 71-75.doi: 10.6040/j.issn.1671-7554.0.2016.1195

CT矢状位重建在膈顶部肝肿瘤微波消融治疗中的应用

王宁宁¹,曲琳莉¹,曹芳丽^1,2,梁磊¹

1.山东大学齐鲁医院(青岛)化疗科, 山东青岛 266035;2.聊城市人民医院肿瘤科, 山东聊城 252000

收稿日期:2016-09-23 出版日期:2017-08-10 发布日期:2017-08-10
通讯作者: 曹芳丽. E-mail:fanglicaochina@163.com E-mail:fanglicaochina@163.com
基金资助:
山东省自然科学基金(ZR2014HL057)

Application of computed tomography sagittal reconstruction for microwave ablation of hepatic carcinoma under the diaphragm

WANG Ningning¹, QU Linli¹, CAO Fangli^1,2, LIANG Lei¹

1. Department of Chemotherapy, Qilu Hospital of Shandong University, Qingdao 266035, Shandong, China;
2. Department of Oncology, Liaocheng Peoples Hospital, Liaocheng 252000, Shandong, China

Received:2016-09-23 Online:2017-08-10 Published:2017-08-10

摘要/Abstract

摘要： 目的评估CT矢状位重建下经皮微波消融治疗膈顶部肝肿瘤的疗效。方法 8例原发性肝癌、2例肝转移瘤患者,共11枚肿瘤病灶,在CT矢状位重建下进行微波消融治疗,随访36个月,观察肿瘤清除率、局部复发率、生存率、远处转移及血清AFP变化。结果全组11枚肿瘤病灶完全清除率为90.9%;3例术前AFP≥200 ng/mL者中1例术后AFP<200 ng/mL(1/3);1、2、3年肿瘤局部复发率分别为20%、30%、30%;1、2、3年生存率分别为100%(10/10)、60%(6/10)、 50%(5/10)。所有患者均未出现操作相关的严重并发症。结论 CT矢状位重建下微波消融治疗膈顶部肝肿瘤是无法治疗或拒绝外科手术切除肝肿瘤患者的有效治疗方法。

关键词: 微波消融, CT矢状位重建, 膈顶, 肝癌

Abstract: Objective To evaluate the efficacy of computed tomography(CT)sagittal reconstruction for microwave ablation of hepatic tumor under the diaphragm. Methods A total of 8 patients with primary liver cancer and 2 patients with hepatic metastases(altogether 11 lesions)who underwent microwave ablation with CT sagittal reconstruction were involved. During the follow-up of 36 months, the tumor clearance rate, local recurrence rate, survival rate, distant metastasis and changes of alpha fetal protein(AFP)were observed. Results The overall clearance rate was 90.9%. Of the 3 patients with preoperative AFP ≥ 200 ng/mL, 1 patient had AFP reduced to < 200 ng/mL. The 1-, 2- and 3-year local recurrence rate was 20%, 30% and 30%. The 1-, 2- and 3-year overall survival(OS)was 100%, 60% and 50%. No serious operation-related complications were observed. Conclusion Microwave ablation of hepatic carcinoma under the diaphragm with CT sagittal reconstruction is a preferred method if patients are unresectable.

Key words: Hepatic carcinoma, CT Sagittal reconstruction, Microwave ablation, Under the diaphragm

中图分类号:

R735.7

王宁宁,曲琳莉,曹芳丽,梁磊. CT矢状位重建在膈顶部肝肿瘤微波消融治疗中的应用[J]. 山东大学学报（医学版）, 2017, 55(8): 71-75.

WANG Ningning, QU Linli, CAO Fangli, LIANG Lei. Application of computed tomography sagittal reconstruction for microwave ablation of hepatic carcinoma under the diaphragm[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 71-75.

参考文献

[1] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[2] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 临床肿瘤学杂志,2011,16(10):929-946.
[3] 谭凯, 杜锡林, 杨涛, 等. 肝癌合并门静脉癌栓术后门静脉化疗疗效分析[J]. 西部医学, 2015, 27(7): 989-995. TAN Kai, DU Xilin, YANG Tao, et al. The efficacy of portal vein chemotherapy on patients with liver cancer complicated with portal vein tumor thrombus undergoing hepatectomy[J]. Med J West China, 2015, 27(7): 989-995.
[4] Weledji EP, Enow Orock G, Ngowe MN, et al. How grim is hepatocellular carcinoma[J]. Ann Med Surg(Lond), 2014, 3(3): 71-76.
[5] 庄兴俊, 王宁宁, 侯晓玮, 等. 影像引导下经皮微波局部消融治疗原发性肝癌疗效观察[J]. 中华消化病与影像杂志, 2013, 3(3): 32-34.
[6] 曾鹏, 周乐杜, 王栋, 等. 射频消融治疗小肝癌疗效及预后因素分析[J]. 中国普通外科杂志, 2014, 23(7): 904-909. ZENG Peng, ZHOU Ledu, WANG Dong, et al. Radiofrequency ablation for small hepatocellular carcinoma: efficacy and prognostic factors[J]. Chinese Journal of General Surgery, 2014, 23(7): 904-909.
[7] 许贇, 王能, 沈强, 等. 经皮热消融治疗极早期肝癌的疗效及预后因素分析[J].中国普通外科杂志, 2015, 24(7): 945-951. XU Yun, WANG Neng, SHEN Qiang, et al. Percutaneous thermal ablation for very early stage hepatocellular carcinoma: efficacy and prognostic factors[J]. Chinese Journal of General Surgery, 2015, 24(7): 945-951.
[8] Hoffmann R, Rempp H, Erhard L, et al. Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver[J]. Radiology, 2013, 268(1): 89-97.
[9] Fang Y, Chen W, Liang X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma[J]. J Gastroen Hepatol, 2014, 29(1): 193-200.
[10] Shi J, Sun Q, Wang Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria[J]. J Gastroen Hepatol, 2014, 29(7): 1500-1507.
[11] Medhat E, Abdel Aziz A, Nabeel M, et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma[J]. J Dig Dis, 2015, 16(8): 345-463.
[12] 庄兴俊, 王宁宁, 侯晓玮, 等. 人工气胸后氩氦刀冷冻治疗近膈顶部肝癌4例[J]. 中华肝脏病杂志, 2012, 20(6): 479.
[13] Peng ZW, Lin XJ, Zhang YJ, et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study[J]. Radiology, 2012, 262(3): 1022-1033.
[14] Wu F, Wang ZB, Chen WZ, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma[J]. Ann Surg Oncol, 2004, 11(12): 1061-1069.
[15] Gómez Portilla A1, Cendoya I, Olabarría I, et al. The European contribution to “Sugarbakers protocol” for the treatment of colorectal peritoneal carcinomatosis[J]. Rev Esp Enferm Dig, 2009, 101(2): 97-102, 103-106.
[16] Pathak S, Jones R, Tang JM, et al. Ablative therapies for colorectal liver metastases: a systematic review[J]. Colorectal Dis, 2011, 13(9): e252-265.

相关文章 15

[1]	田丽君,桑玉洁,孙瑜婧,韩冰,秦成勇,祁建妮. 全身免疫炎症指数对原发性肝癌患者免疫检查点抑制剂治疗相关不良反应的预测价值[J]. 山东大学学报 (医学版), 2024, 62(6): 48-53.
[2]	靳新娟,左立平,邓展昊,李安宁,于德新. MRI影像组学对135例肝癌耐药蛋白PFKFB3的预测价值[J]. 山东大学学报 (医学版), 2023, 61(6): 79-86.
[3]	李博,刘竞芳,鲍金鹏,李祥泽,秦广洋,田虎. 三维可视化联合吲哚菁绿荧光影像技术在51例原发性肝癌腹腔镜切除术中的应用价值[J]. 山东大学学报 (医学版), 2022, 60(3): 83-88.
[4]	左立平,蒋丰洋,周斌彬,范金蕾,梁永锋,邓展昊,于德新. 术前MRI在预测169例肝细胞肝癌微血管侵犯及早期复发的价值[J]. 山东大学学报 (医学版), 2022, 60(3): 89-95.
[5]	马瑞杰,朱良明,左太阳,李春海,张楠,孙志钢. 微波消融治疗非小细胞肺癌根治术后肺寡转移瘤的预后分析[J]. 山东大学学报 (医学版), 2022, 60(12): 63-68.
[6]	柴佳威,朱坤兵,张华伟,崔凤云,王甜甜,田兴松. 1例肝细胞肝癌甲状腺转移罕见病例报道与文献回顾[J]. 山东大学学报 (医学版), 2021, 59(3): 120-124.
[7]	孙薏丰,高玉,梁永媛,高杨. CPLX2在30例肝癌组织的表达及其对体外细胞增殖与侵袭的影响[J]. 山东大学学报 (医学版), 2020, 1(9): 34-39.
[8]	邵倩倩,王景溥,王庆杰. 抗凋亡转录因子在肝细胞肝癌中的表达及预后作用[J]. 山东大学学报 (医学版), 2018, 56(12): 7-12.
[9]	杨飞龙,周尊林,任巨超,闫磊,刘海南, 张温花,俞能旺,李大伟,徐忠华. 肝癌衍生生长因子对前列腺癌细胞增殖的影响及其机制[J]. 山东大学学报 (医学版), 2018, 56(1): 62-69.
[10]	贺武斌,苏荣健. 白头翁皂苷D联合索拉非尼对人肝癌细胞侵袭与转移的影响[J]. 山东大学学报（医学版）, 2016, 54(7): 18-22.
[11]	岳倩倩,王新怡,杨志强,姜舒. 富血供肝脏转移瘤与肝细胞肝癌的能谱CT成像定量分析[J]. 山东大学学报（医学版）, 2016, 54(7): 50-55.
[12]	宗兆运,李霞,韩振龙,王显腾,郭春,张利宁,石永玉. 肿瘤相关巨噬细胞对肝癌细胞c-Met分子表达的影响[J]. 山东大学学报（医学版）, 2016, 54(3): 14-18.
[13]	宋佳, 李鑫, 李丹, 叶丽平. 特异性下调Grp78表达增加肝癌细胞对厄洛替尼的敏感性[J]. 山东大学学报（医学版）, 2015, 53(6): 7-12.
[14]	李雪峰, 王双龙, 于美, 崔红, 孙媛媛, 董磊. 经皮经肝超声造影显像评估兔VX2肝癌腹腔淋巴结转移的实验研究[J]. 山东大学学报（医学版）, 2015, 53(6): 13-17.
[15]	谷旭, 王夏青, 任万华, 秦成勇, 韩国庆. NPRL2、Survivin在肝细胞肝癌中的表达及其临床意义[J]. 山东大学学报（医学版）, 2015, 53(6): 68-72.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

CT矢状位重建在膈顶部肝肿瘤微波消融治疗中的应用

Application of computed tomography sagittal reconstruction for microwave ablation of hepatic carcinoma under the diaphragm

PDF (PC)

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

多维度评价

本文评价

推荐阅读 0